Outcome and Clinical Significance of Immunophenotypic Markers Expressed in different treatment protocols of T-ALL Pediatric Patients in developing countries

Abstract Background T-ALL accounts for about 15% of pediatric ALL. With wider use of intensive chemotherapy, the prognosis for childhood T-ALL has improved. Further gains in treatment outcome will likely require methods to identify patients who continue to fail on contemporary protocols. This study...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2017
Hauptverfasser:	Sayed, Douaa M, Sayed, Heba Abdel Razik, Raslan, Heba N, Ali, Amany M, Zahran, Asmaa, Al-Hayek, Reema, Daama, Saad A, Al-Saber, Arwa
Format:	Artikel
Sprache:	eng
Schlagworte:	Hematology, Oncology and Palliative Medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!